Yusuke Sato

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Venues

Pharmaceutics

ACS applied materials & interfaces

Molecular pharmaceutics

Communications biology

Hokkaido University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hokkaido University Apr 01 2016

Japan

Assistant Professor :: Faculty of Pharmaceutical Sciences

Publications

Kazuki Hashiba, Masamitsu Taguchi, Sachiko Sakamoto, Ayaka Otsu, Yoshiki Maeda, Hirofumi Ebe, Arimichi Okazaki, Hideyoshi Harashima, Yusuke Sato
Overcoming thermostability challenges in mRNA-lipid nanoparticle systems with piperidine-based ionizable lipids. Communications biology 7 (1) (2024)
Kazuki Hashiba, Masamitsu Taguchi, Sachiko Sakamoto, Ayaka Otsu, Yoshiki Maeda, Hirofumi Ebe, Arimichi Okazaki, Hideyoshi Harashima, Yusuke Sato
Overcoming thermostability challenges in mRNA-lipid nanoparticle systems with piperidine-based ionizable lipids. Communications biology 7 (1) (2024)
Takashi Nakamura, Shun Sasaki, Yusuke Sato, Hideyoshi Harashima
Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. Pharmaceutics 16 (1) (2023)
Masatoshi Maeki, Shuya Uno, Kaisei Sugiura, Yusuke Sato, Yoichiro Fujioka, Akihiko Ishida, Yusuke Ohba, Hideyoshi Harashima, Manabu Tokeshi
Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. ACS applied materials & interfaces 16 (2) (2023)
Masatoshi Maeki, Shuya Uno, Kaisei Sugiura, Yusuke Sato, Yoichiro Fujioka, Akihiko Ishida, Yusuke Ohba, Hideyoshi Harashima, Manabu Tokeshi
Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. ACS applied materials & interfaces 16 (2) (2023)
Takashi Nakamura, Shun Sasaki, Yusuke Sato, Hideyoshi Harashima
Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. Pharmaceutics 16 (1) (2023)
Takashi Nakamura, Shun Sasaki, Yusuke Sato, Hideyoshi Harashima
Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. Pharmaceutics 16 (1) (2023)
Masatoshi Maeki, Shuya Uno, Kaisei Sugiura, Yusuke Sato, Yoichiro Fujioka, Akihiko Ishida, Yusuke Ohba, Hideyoshi Harashima, Manabu Tokeshi
Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. ACS applied materials & interfaces 16 (2) (2023)
Jerry Leung, Colton Strong, Katherine E Badior, Madelaine K Robertson, Xiaowu Wu, Michael Adam Meledeo, Emma Kang, Manoj Paul, Yusuke Sato, Hideyoshi Harashima, Andrew P Cap, Dana V Devine, Eric Jan, Pieter R Cullis, Christian J Kastrup
Genetically engineered transfusable platelets using mRNA lipid nanoparticles. Science advances 9 (48) (2023)
Masatoshi Maeki, Shuya Uno, Kaisei Sugiura, Yusuke Sato, Yoichiro Fujioka, Akihiko Ishida, Yusuke Ohba, Hideyoshi Harashima, Manabu Tokeshi
Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection. ACS applied materials & interfaces (2023)
Kosuke Sasaki, Yusuke Sato, Kento Okuda, Kazuki Iwakawa, Hideyoshi Harashima
mRNA-Loaded Lipid Nanoparticles Targeting Dendritic Cells for Cancer Immunotherapy. Pharmaceutics 14 (8) (2022)
Takafumi Fukui, Hironao Tateno, Takashi Nakamura, Yuma Yamada, Yusuke Sato, Norimasa Iwasaki, Hideyoshi Harashima, Ken Kadoya
Retrograde Axonal Transport of Liposomes from Peripheral Tissue to Spinal Cord and DRGs by Optimized Phospholipid and CTB Modification. International journal of molecular sciences 23 (12) (2022)
Jinyuan Luo, Greymi Tan, Kai Xin Thong, Konstantinos N Kafetzis, Neeru Amrita Vallabh, Carl M Sheridan, Yusuke Sato, Hideyoshi Harashima, Aristides D Tagalakis, Cynthia Yu-Wai-Man
Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery. Pharmaceutics 14 (11) (2022)
Saed Abbasi, Haruki Higashino, Yusuke Sato, Keiko Minami, Makoto Kataoka, Shinji Yamashita, Hideyoshi Harashima
Maximizing the Oral Bioavailability of Poorly Water-Soluble Drugs Using Novel Oil-Like Materials in Lipid-Based Formulations. Molecular pharmaceutics 18 (9) (2021)
Ian Baudi, Masanori Isogawa, Federica Moalli, Masaya Onishi, Keigo Kawashima, Yuji Ishida, Chise Tateno, Yusuke Sato, Hideyoshi Harashima, Hiroyasu Ito, Tetsuya Ishikawa, Takaji Wakita, Matteo Iannacone, Yasuhito Tanaka
Interferon signaling suppresses the unfolded protein response and induces cell death in hepatocytes accumulating hepatitis B surface antigen. PLoS pathogens 17 (5) (2021)
Saed Abbasi, Yusuke Sato, Kazuaki Kajimoto, Hideyoshi Harashima
New Design Strategies for Controlling the Rate of Hydrophobic Drug Release from Nanoemulsions in Blood Circulation. Molecular pharmaceutics 17 (10) (2020)
Yusuke Shiozawa, Luca Malcovati, Anna Gallì, Andrea Pellagatti, Mohsen Karimi, Aiko Sato-Otsubo, Yusuke Sato, Hiromichi Suzuki, Tetsuichi Yoshizato, Kenichi Yoshida, Yuichi Shiraishi, Kenichi Chiba, Hideki Makishima, Jacqueline Boultwood, Eva Lindberg, Satoru Miyano, Mario Cazzola, Seishi Ogawa
Gene expression and risk of leukemic transformation in myelodysplasia. Blood 130 (24) (2017)

Yusuke Sato.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yusuke Sato